Psoriasis Cream: A Dermatologist’s Guide to Topical Treatments That Actually Work

Why Choosing the Right Psoriasis Cream Matters

If you have psoriasis, you have almost certainly tried a cream, ointment, or lotion at some point. Topical therapy is the foundation of psoriasis management for the roughly 80% of patients with mild-to-moderate disease [1]. But standing in the pharmacy aisle (or scrolling through options online) can feel overwhelming. Prescription steroids, vitamin D creams, coal tar, salicylic acid, brand-new non-steroidal options, thick emollients: how do you know what actually works?

The answer depends on where your plaques are, how thick they are, and what you have tried before. This guide walks through every major category of psoriasis cream, explains the evidence behind each, and gives you a practical framework for layering and rotating treatments safely.

Topical Corticosteroids: The Workhorse of Psoriasis Treatment

Corticosteroid creams are the first-line topical treatment for psoriasis in most guidelines worldwide [2]. They reduce inflammation, slow skin cell turnover, and relieve itching, often within days. The critical variable is potency.

Understanding Potency Classes

Topical steroids are ranked on a seven-class scale in the United States (Class I is strongest, Class VII is weakest). For psoriasis, clinicians typically start in the mid-to-high range because plaques are thicker and more resistant than typical eczema patches [2].

• Super-high potency (Class I): Clobetasol propionate 0.05%, betamethasone dipropionate augmented 0.05%. Reserved for thick plaques on the body, palms, and soles. Use is generally limited to two consecutive weeks.
• High potency (Class II-III): Fluocinonide 0.05%, desoximetasone 0.25%. A common starting point for moderate trunk and extremity plaques.
• Medium potency (Class IV-V): Triamcinolone acetonide 0.1%, fluticasone propionate 0.05%. Appropriate for thinner skin areas or maintenance phases.
• Low potency (Class VI-VII): Hydrocortisone 1-2.5%, desonide 0.05%. Best for the face, groin, and axillae where skin is thinner and more prone to steroid side effects.

Steroid Rotation to Prevent Skin Thinning

Long-term continuous use of potent steroids can cause atrophy (thinning), striae (stretch marks), telangiectasia (visible blood vessels), and rebound flares when stopped abruptly [3]. The standard clinical approach is a “pulse” or rotation strategy:

• Apply a potent steroid daily for 2 to 4 weeks to bring plaques under control.
• Step down to a lower-potency steroid or switch to a non-steroidal agent (vitamin D analog, calcineurin inhibitor) for maintenance.
• Some clinicians recommend “weekend therapy,” using the potent steroid only on weekends while applying a non-steroidal agent on weekdays [3].

This rotation preserves efficacy while giving the skin time to recover. If you find yourself needing a super-potent steroid continuously, that is a signal to discuss systemic or biologic therapy with your dermatologist.

Vitamin D Analogs: Calcipotriene and Beyond

Calcipotriene (calcipotriol outside the U.S.) is a synthetic vitamin D3 derivative that slows keratinocyte proliferation and promotes normal differentiation of skin cells [4]. It does not cause skin thinning, making it a valuable long-term option.

On its own, calcipotriene is modestly effective. Head-to-head data show it is roughly equivalent to a mid-potency steroid for plaque reduction, though it works a bit more slowly [4]. The real advantage appears when you combine it with a steroid. The combination product calcipotriene/betamethasone dipropionate (marketed as Taclonex or Enstilar) consistently outperforms either ingredient alone, with faster clearance and higher patient satisfaction scores [5].

Practical tips for vitamin D analogs:

• They can cause mild irritation or burning when first applied, especially on thinner skin. This usually fades after a week.
• Do not exceed 100 grams per week of calcipotriene, as excessive use can theoretically raise calcium levels (though this is rare in practice) [4].
• They pair well with phototherapy and can be applied on “steroid-off” days in a rotation schedule.

Coal Tar Preparations

Coal tar is one of the oldest psoriasis treatments on record, and it still works. Tar reduces inflammation, slows cell turnover, and has anti-itch properties. Modern formulations are far more cosmetically acceptable than the thick, pungent products of decades past [6].

OTC coal tar shampoos (like Neutrogena T/Gel) and creams (typically 1-5% concentration) are widely available and can be effective for mild scalp and body psoriasis. Prescription-strength preparations (up to 20% crude coal tar) are less commonly used today but remain an option for patients who prefer to avoid steroids entirely [6].

The main drawbacks are the smell, potential staining of clothing, and photosensitivity (avoid sun exposure on treated areas for 24 hours). Historically there were concerns about carcinogenicity, but large cohort studies of patients using coal tar for psoriasis have not demonstrated a meaningful increase in skin cancer risk [6].

Salicylic Acid: The Keratolytic Partner

Salicylic acid is not an anti-inflammatory in the way steroids are. Instead, it works as a keratolytic, softening and dissolving the thick scale that sits on top of psoriasis plaques [7]. This is valuable because thick scale acts as a physical barrier, preventing other active ingredients from reaching the skin.

Concentrations of 2-6% are typical in OTC products (lotions, shampoos, ointments). Many clinicians recommend applying salicylic acid first to “de-scale” a plaque, then following with a steroid or vitamin D cream 20 to 30 minutes later for better penetration [7]. For scalp psoriasis specifically, a salicylic acid shampoo used before a medicated treatment can make a noticeable difference in how well the medication works.

Newer Non-Steroidal Topicals: Tapinarof and Roflumilast

Two relatively recent FDA approvals have changed the topical landscape for psoriasis. Both offer steroid-free mechanisms with strong efficacy data.

Tapinarof (Vtama) 1% Cream

Tapinarof is an aryl hydrocarbon receptor (AhR) agonist, a completely novel mechanism for psoriasis. It modulates skin immune responses and restores barrier function. In phase 3 trials, about 36-40% of patients achieved clear or almost clear skin at 12 weeks, and responses continued to improve with longer use [8]. Notably, some patients maintained remission for months after stopping treatment (a phenomenon researchers have called a “remittive effect”), which is unusual for any topical agent [8].

Tapinarof can be used on all body areas, including sensitive sites like the face and skin folds, without concerns about thinning. The most common side effect is folliculitis (small bumps around hair follicles) at the application site, reported in about 20% of patients [8].

Roflumilast (Zoryve) 0.3% Cream

Roflumilast is a phosphodiesterase-4 (PDE4) inhibitor applied topically. PDE4 inhibition raises intracellular cyclic AMP levels, which dampens the inflammatory cascade driving psoriasis [9]. In clinical trials, roughly 38-42% of patients hit clear or almost clear status at 8 weeks [9]. Like tapinarof, it is safe for use on the face, skin folds, and other sensitive areas.

Roflumilast cream is generally well tolerated. Some patients report mild application-site reactions, but discontinuation rates due to side effects are low [9]. It is also FDA-approved for atopic dermatitis (at a different concentration), so patients with both conditions may find it especially convenient.

Moisturizers and Emollients: The Unsung Foundation

No psoriasis cream regimen is complete without a solid moisturizer. Emollients do not directly treat the immune dysfunction of psoriasis, but they repair the disrupted skin barrier, reduce transepidermal water loss, and can decrease scaling and itching on their own [10]. Several randomized trials show that regular emollient use extends the time between flares and reduces the amount of steroid needed [10].

For psoriasis specifically, look for:

• Ceramide-containing creams (like CeraVe Psoriasis Moisturizing Cream), which help restore lipid layers in the stratum corneum.
• Thick ointment bases (petrolatum, Aquaphor) for very dry or cracked plaques, especially overnight.
• Fragrance-free and dye-free formulations to minimize irritation.

Apply moisturizer liberally after bathing (within 3 minutes of toweling off to lock in hydration) and reapply throughout the day as needed.

How to Layer Your Psoriasis Treatments

When using multiple topicals, order matters. A general layering sequence:

1. Keratolytic first (salicylic acid product) if plaques are thick and scaly. Allow 20-30 minutes to work, or use it in a separate application session (morning vs. evening).
2. Active treatment (steroid, vitamin D analog, tapinarof, or roflumilast). Apply a thin layer directly to plaques.
3. Moisturizer last (over the entire area, including surrounding skin). Wait 10-15 minutes after applying the active treatment so it absorbs before sealing with emollient.

For combination steroid/calcipotriene products, the active treatment step is simplified into a single application. If using separate steroid and calcipotriene products, some guidelines suggest applying them at different times of day (steroid in the morning, calcipotriene at night) to avoid potential pH interactions that could reduce calcipotriene stability [5].

OTC vs. Prescription: What Can You Get Without a Doctor Visit?

Several effective psoriasis creams are available over the counter:

• Hydrocortisone 1%: Mild steroid suitable for thin-skinned areas and brief flare management.
• Coal tar (1-5%): Shampoos, creams, and lotions for scalp and body.
• Salicylic acid (2-3%): Descaling products for thick plaques.
• Ceramide moisturizers: Daily barrier repair.

Prescription-only options include all medium-to-super-potent steroids, calcipotriene (and combination products), tapinarof, roflumilast, and tazarotene (a topical retinoid sometimes used for plaque psoriasis) [11]. If OTC products are not controlling your symptoms within 4 to 6 weeks, or if plaques are spreading, a dermatology visit is the logical next step.

Special Considerations by Body Site

Scalp

Scalp psoriasis is notoriously stubborn because hair makes cream application difficult. Solutions, foams, and shampoos tend to work better than thick creams here. Clobetasol foam or solution is a common first-line prescription. A salicylic acid shampoo used 2-3 times weekly can help lift scale before applying medicated products [12].

Face and Skin Folds

These areas absorb steroids more readily, increasing the risk of thinning and other side effects. Low-potency steroids (hydrocortisone, desonide) are appropriate for short courses. Calcineurin inhibitors (tacrolimus, pimecrolimus), while technically off-label for psoriasis, are sometimes used here. Tapinarof and roflumilast are excellent choices for these sensitive areas because they carry no atrophy risk [8][9].

Palms and Soles

The thick skin on palms and soles resists penetration, so super-potent steroids (clobetasol ointment) are often needed. Occlusion (covering with plastic wrap or cotton gloves overnight) can boost absorption significantly [12].

When Topicals Are Not Enough

Topical therapy has its limits. If psoriasis covers more than about 5-10% of body surface area, applying creams everywhere becomes impractical and systemic therapy (methotrexate, biologics, oral PDE4 inhibitors like apremilast) typically delivers better outcomes [13]. That said, many patients on systemic therapy still use topical creams for residual plaques or localized flares, so understanding these products remains relevant regardless of disease severity.

Putting It All Together

The best psoriasis cream strategy is a layered, rotating approach rather than reliance on a single product. Start with moisturizers as the daily foundation. Add an active treatment matched to plaque thickness and location. Rotate steroids to prevent thinning, and consider newer non-steroidal options (tapinarof, roflumilast) for long-term maintenance or sensitive areas. Track your response over 4 to 8 weeks and adjust with your clinician based on results.

Topical treatment for psoriasis has genuinely improved in the last few years. With more non-steroidal options, better combination products, and a clearer understanding of how to rotate therapies, achieving comfortable skin is a realistic goal for most people with mild-to-moderate disease.

Related Reading

• Psoriasis: Complete Guide

References

1. Menter A, Strober BE, Kaplan DH, et al. “Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with topical therapy.” J Am Acad Dermatol. 2020;82(4):1029-1044. doi:10.1016/j.jaad.2019.07.087
2. Samarasekera EJ, Sawyer L, Wonderling D, et al. “Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses.” Br J Dermatol. 2013;168(5):954-967. doi:10.1111/bjd.12071
3. Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. “Adverse effects of topical glucocorticosteroids.” J Am Acad Dermatol. 2006;54(1):1-15. doi:10.1016/j.jaad.2005.01.010
4. Kragballe K, Iversen L. “Calcipotriol: a new topical antipsoriatic.” Dermatol Clin. 1993;11(1):137-141. doi:10.1016/S0733-8635(18)30289-6
5. Koo J, Tyring S, Werschler WP, et al. “Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris.” J Am Acad Dermatol. 2016;74(6):1099-1105. doi:10.1016/j.jaad.2015.11.039
6. Roelofzen JH, Aben KK, Oldenhof UT, et al. “No increased risk of cancer after coal tar treatment in patients with psoriasis or eczema.” J Invest Dermatol. 2010;130(4):953-961. doi:10.1038/jid.2009.389
7. Lebwohl M, Ali S. “Treatment of psoriasis. Part 1. Topical therapy and phototherapy.” J Am Acad Dermatol. 2001;45(4):487-498. doi:10.1067/mjd.2001.117046
8. Lebwohl MG, Stein Gold L, Strober B, et al. “Phase 3 trials of tapinarof cream for plaque psoriasis.” N Engl J Med. 2021;385(24):2219-2229. doi:10.1056/NEJMoa2103629
9. Lebwohl MG, Kircik LH, Moore AY, et al. “Once-daily roflumilast cream for plaque psoriasis: phase 3 DERMIS-1 and DERMIS-2 trials.” J Am Acad Dermatol. 2022;87(5):1044-1052. doi:10.1016/j.jaad.2022.07.060
10. Lindh JD, Bradley M. “Clinical effectiveness of moisturizers in atopic dermatitis and related disorders: a systematic review.” Am J Clin Dermatol. 2015;16(5):341-359. doi:10.1007/s40257-015-0146-4
11. Van de Kerkhof PC, Franssen ME. “Subclinical changes in psoriatic skin during topical treatment.” Skin Pharmacol Physiol. 2019;32(2):58-65. doi:10.1159/000495409
12. Menter A, Korman NJ, Elmets CA, et al. “Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 3.” J Am Acad Dermatol. 2009;60(4):643-659. doi:10.1016/j.jaad.2008.12.032
13. Armstrong AW, Read C. “Pathophysiology, clinical presentation, and treatment of psoriasis: a review.” JAMA. 2020;323(19):1945-1960. doi:10.1001/jama.2020.4006